Literature DB >> 6206142

A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo.

C Linington, S Izumo, M Suzuki, K Uyemura, R Meyermann, H Wekerle.   

Abstract

A rat T cell line of the "helper" phenotype (W3/25-positive, OX 8-negative) has been derived from Lewis rats inoculated with P2 protein isolated from bovine PNS myelin. The line LiP2/A is exquisitely specific for P2 protein, exhibiting no reactivity to bovine basic protein or to PPD. In addition to responding strongly to the intact P2 protein, the line cells show some response to a synthetic peptide containing the neuritogenic amino acid sequence of P2 protein (SP-B, residues 66-78). Intravenous inoculation of naive rats with as few as 10(4) activated LiP2/A cells leads to the onset of mild clinical signs of experimental allergic neuritis. Higher doses of cells lead to more severe clinical disease. Histologic examination of clinically ill animals confirmed the disease as EAN. The pathologic lesions were confined to the PNS and spared the central nervous system. The lesions consisted of marked perivascular cuffs and infiltrates of inflammatory cells associated with marked degenerative changes--demyelination and some axonal degeneration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.

Authors:  M Stienekemeier; K Falk; O Rötzschke; A Weishaupt; C Schneider; K V Toyka; R Gold; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.

Authors:  Yong Peng; Gencheng Han; Hui Shao; Yali Wang; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

3.  T lymphocyte autoimmunity in peripheral nervous system autoimmune disease.

Authors:  C Linington; H Wekerle; R Meyermann
Journal:  Agents Actions       Date:  1986-12

4.  Adoptive transfer of experimental allergic neuritis in the immune suppressed host.

Authors:  A F Hahn; T E Feasby; D Lovgren; L Wilkie
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 5.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2.

Authors:  A Weishaupt; R Gold; S Gaupp; G Giegerich; H P Hartung; K V Toyka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

7.  Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.

Authors:  J Zhu; X F Bai; G Hedlund; J Björk; M Bakhiet; P H Van Der Meide; H Link
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

8.  Relationship of adjuvants and swine influenza vaccine to experimental neuropathy in rabbits.

Authors:  H C Powell; A P Mizisin; C A Wiley; M K Morey; R A Hughes
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 9.  Guillain-Barré syndrome: a century of progress.

Authors:  John A Goodfellow; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2016-11-18       Impact factor: 42.937

10.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.